• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子-D 受体结合和特异性的结构决定因素。

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.

机构信息

Molecular Cancer Biology Program, Research Programs Unit, Haartman Institute, Institute for Molecular Medicine Finland and Helsinki University Central Hospital, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.

出版信息

Blood. 2011 Feb 3;117(5):1507-15. doi: 10.1182/blood-2010-08-301549. Epub 2010 Dec 8.

DOI:10.1182/blood-2010-08-301549
PMID:21148085
Abstract

Vascular endothelial growth factors (VEGFs) and their tyrosine kinase receptors (VEGFR-1-3) are central mediators of angiogenesis and lymphangiogenesis. VEGFR-3 ligands VEGF-C and VEGF-D are produced as precursor proteins with long N- and C-terminal propeptides and show enhanced VEGFR-2 and VEGFR-3 binding on proteolytic removal of the propeptides. Two different proteolytic cleavage sites have been reported in the VEGF-D N-terminus. We report here the crystal structure of the human VEGF-D Cys117Ala mutant at 2.9 Å resolution. Comparison of the VEGF-D and VEGF-C structures shows similar extended N-terminal helices, conserved overall folds, and VEGFR-2 interacting residues. Consistent with this, the affinity and the thermodynamic parameters for VEGFR-2 binding are very similar. In comparison with VEGF-C structures, however, the VEGF-D N-terminal helix was extended by 2 more turns because of a better resolution. Both receptor binding and functional assays of N-terminally truncated VEGF-D polypeptides indicated that the residues between the reported proteolytic cleavage sites are important for VEGF-D binding and activation of VEGFR-3, but not of VEGFR-2. Thus, we define here a VEGFR-2-specific form of VEGF-D that is angiogenic but not lymphangiogenic. These results provide important new insights into VEGF-D structure and function.

摘要

血管内皮生长因子 (VEGFs) 及其酪氨酸激酶受体 (VEGFR-1-3) 是血管生成和淋巴管生成的主要介质。VEGFR-3 配体 VEGF-C 和 VEGF-D 作为前体蛋白产生,具有长的 N-和 C-末端前肽,并在前肽的蛋白水解去除后显示增强的 VEGFR-2 和 VEGFR-3 结合。在 VEGF-D N 末端已经报道了两个不同的蛋白水解切割位点。我们在这里报告了 2.9 Å 分辨率的人 VEGF-D Cys117Ala 突变体的晶体结构。VEGF-D 和 VEGF-C 结构的比较表明,它们具有相似的延伸 N 末端螺旋、保守的整体折叠和与 VEGFR-2 相互作用的残基。与此一致,VEGFR-2 结合的亲和力和热力学参数非常相似。然而,与 VEGF-C 结构相比,由于分辨率更高,VEGF-D N 末端螺旋延伸了 2 个额外的螺旋。N 末端截短的 VEGF-D 多肽的受体结合和功能测定均表明,报道的蛋白水解切割位点之间的残基对于 VEGF-D 与 VEGFR-3 的结合和激活很重要,但对于 VEGFR-2 则不重要。因此,我们在这里定义了一种 VEGFR-2 特异性的 VEGF-D 形式,它具有血管生成作用但没有淋巴管生成作用。这些结果为 VEGF-D 的结构和功能提供了重要的新见解。

相似文献

1
Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.血管内皮生长因子-D 受体结合和特异性的结构决定因素。
Blood. 2011 Feb 3;117(5):1507-15. doi: 10.1182/blood-2010-08-301549. Epub 2010 Dec 8.
2
Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.淋巴管生成生长因子血管内皮生长因子(VEGF)-C和-D的差异受体结合及调控机制
J Biol Chem. 2016 Dec 30;291(53):27265-27278. doi: 10.1074/jbc.M116.736801. Epub 2016 Nov 16.
3
Structural determinants of growth factor binding and specificity by VEGF receptor 2.VEGF 受体 2 结合和特异性的结构决定因素。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2425-30. doi: 10.1073/pnas.0914318107.
4
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.酪氨酸激酶抑制剂西地尼布可阻断配体诱导的血管内皮生长因子受体-3活性及淋巴管生成。
Cancer Res. 2008 Jun 15;68(12):4754-62. doi: 10.1158/0008-5472.CAN-07-5809.
5
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.VEGF-D 的前肽决定肝素结合、受体异二聚化以及对肿瘤生物学的影响。
J Biol Chem. 2013 Mar 22;288(12):8176-8186. doi: 10.1074/jbc.M112.439299. Epub 2013 Feb 12.
6
Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns.血管内皮生长因子(VEGF)/VEGF - C嵌合分子揭示了特异性决定因素并具有新型受体结合模式。
J Biol Chem. 2006 Apr 28;281(17):12187-95. doi: 10.1074/jbc.M511593200. Epub 2006 Feb 27.
7
Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation.血管内皮生长因子受体 3 配体结合与激活的结构与机制研究进展。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12960-5. doi: 10.1073/pnas.1301415110. Epub 2013 Jul 22.
8
Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.主动脉瓣狭窄中的淋巴管生成——瓣膜成纤维细胞和肥大细胞的新调节作用。
Atherosclerosis. 2012 Apr;221(2):366-74. doi: 10.1016/j.atherosclerosis.2011.12.034. Epub 2011 Dec 29.
9
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.纤溶酶激活淋巴管生成生长因子VEGF-C和VEGF-D。
J Exp Med. 2003 Sep 15;198(6):863-8. doi: 10.1084/jem.20030361. Epub 2003 Sep 8.
10
Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2.前蛋白转化酶促进血管内皮生长因子-D(VEGF-D)的加工,这是与血管生成受体VEGFR-2结合的关键步骤。
FASEB J. 2007 Apr;21(4):1088-98. doi: 10.1096/fj.06-7060com. Epub 2007 Jan 22.

引用本文的文献

1
Clinical evaluation of [Tc]Tc-PSMA-P1: a promising SPECT radiotracer for prostate cancer imaging.[锝]Tc-PSMA-P1的临床评估:一种用于前列腺癌成像的有前景的单光子发射计算机断层显像(SPECT)放射性示踪剂。
RSC Adv. 2025 Aug 18;15(35):29097-29108. doi: 10.1039/d5ra04397b. eCollection 2025 Aug 11.
2
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.健康与疾病中的血管内皮生长因子信号传导:从分子机制到治疗前景
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
3
Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.
超越血管:揭示血管内皮生长因子对神经元功能和结构的影响
J Biomed Sci. 2025 Mar 6;32(1):33. doi: 10.1186/s12929-025-01128-8.
4
Molecular Characterization and Interaction between Human VEGF-D and VEGFR-3.人血管内皮生长因子-D(VEGF-D)与血管内皮生长因子受体-3(VEGFR-3)之间的分子特征及相互作用
J Microbiol Biotechnol. 2024 Dec 28;34(12):2627-2636. doi: 10.4014/jmb.2409.09060. Epub 2024 Nov 20.
5
Variations of VEGFR2 Chemical Space: Stimulator and Inhibitory Peptides.VEGFR2 化学空间的变化:刺激肽和抑制肽。
Int J Mol Sci. 2024 Jul 16;25(14):7787. doi: 10.3390/ijms25147787.
6
Case Report: The compound heterozygotes variants in causes autosomal recessive hereditary lymphedema in a Chinese family.病例报告: 中的复合杂合子变异导致一个中国家庭患常染色体隐性遗传性淋巴水肿。
Front Genet. 2023 Mar 22;14:1140406. doi: 10.3389/fgene.2023.1140406. eCollection 2023.
7
Expansion and collapse of VEGF diversity in major clades of the animal kingdom.动物王国主要进化枝中 VEGF 多样性的扩展和崩溃。
Angiogenesis. 2023 Aug;26(3):437-461. doi: 10.1007/s10456-023-09874-9. Epub 2023 Apr 5.
8
Bioactive VEGF-C from E. coli.大肠杆菌来源的生物活性 VEGF-C。
Sci Rep. 2022 Oct 28;12(1):18157. doi: 10.1038/s41598-022-22960-0.
9
KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?KLK3 在血管生成调控中的作用——促进还是抑制肿瘤发生?
Int J Mol Sci. 2021 Dec 17;22(24):13545. doi: 10.3390/ijms222413545.
10
A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics.血管内皮生长因子药理学配体的结构概述:从大分子到设计的肽模拟物。
Molecules. 2021 Nov 9;26(22):6759. doi: 10.3390/molecules26226759.